Search results
Results from the WOW.Com Content Network
Mayo Clinic cardiovascular risk calculator estimates atherosclerotic cardiovascular disease (ASCVD) risk and provides management strategies for patients ages 40 to 75 years with LDL levels >70 and <190 mg/dL.
The Statin Choice Decision AID helps patients make informed decisions about statin use for managing cholesterol and reducing heart disease risk.
The ASCVD Risk Estimator Plus helps clinicians implement guideline-recommended risk equations to facilitate clinician-patient discussion and support decision making to optimize care and lower risk for atherosclerotic cardiovascular disease (ASCVD).
Cardiovascular disease calculators developed by Mayo Clinic for use by medical professionals.
The ASCVD Risk Calculator assesses heart disease risk. It also shows the impact specific therapies can have on decreasing this risk. You can take a heart risk assessment online, via a smartphone app or at your provider’s office.
ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC. Estimates 10-year risk of heart disease or stroke to guide management strategies.
The CAC score can be used as an input for a revised or individualized 10-year ASCVD risk estimate, most notably by using The Multi-Ethnic Study of Atherosclerosis (MESA) calculator. 2 Similar to the rest of the authors’ algorithm, by incorporating the CAC score into the MESA calculator, clinicians can determine a risk score that is ...
With more than 70,000 uses worldwide and policy endorsements for its use (JAMA article), the Mayo Clinic Statin Choice Decision-Aid tool is helping patients and their clinicians have meaningful conversations about whether or not to use statins to reduce cardiovascular (CV) risk.
This Risk Estimator enables health care providers and patients to estimate 10-year and lifetime risks for atherosclerotic cardiovascular disease (ASCVD), defined as coronary death or nonfatal myocardial infarction, or fatal or nonfatal stroke, based on the Pooled Cohort Equations and lifetime risk prediction tools.
Estimate a patient's initial 10-year ASCVD risk using the pooled cohort equation. Receive an individualized, evidence-based, risk-guided intervention approach for managing primary prevention of ASCVD. Project the impact of specific interventions on a patient's risk.